{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T23:14:25Z","timestamp":1770419665449,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Open access funding provided by University of Lausanne"},{"DOI":"10.13039\/501100006390","name":"University of Lausanne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s40262-025-01585-2","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:59:49Z","timestamp":1763632789000},"page":"229-240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Population Pharmacokinetics of Propofol in Critically Ill Patients with and Without Extracorporeal Membrane Oxygenation"],"prefix":"10.1007","volume":"65","author":[{"given":"St\u00e9phane","family":"Bertin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Haefliger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent A.","family":"Decosterd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rapha\u00ebl","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Assouline","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Buclin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monia","family":"Guidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7427-5953","authenticated-orcid":false,"given":"Fran\u00e7oise","family":"Livio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"1585_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40262-023-01213-x","volume":"62","author":"D Morales Castro","year":"2023","unstructured":"Morales Castro D, Dresser L, Granton J, Fan E. Pharmacokinetic alterations associated with critical illness. Clin Pharmacokinet. 2023;62:209\u201320.","journal-title":"Clin Pharmacokinet"},{"key":"1585_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jama.2019.9302","volume":"322","author":"D Brodie","year":"2019","unstructured":"Brodie D, Slutsky AS, Combes A. Extracorporeal life support for adults with respiratory failure and related indications: a review. JAMA. 2019;322:557.","journal-title":"JAMA"},{"key":"1585_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0140-6736(20)31047-3","volume":"396","author":"A Combes","year":"2020","unstructured":"Combes A, Price S, Slutsky AS, Brodie D. Temporary circulatory support for cardiogenic shock. Lancet. 2020;396:199\u2013212.","journal-title":"Lancet"},{"key":"1585_CR4","doi-asserted-by":"publisher","first-page":"741.e9","DOI":"10.1016\/j.jcrc.2012.02.013","volume":"27","author":"K Shekar","year":"2012","unstructured":"Shekar K, Fraser JF, Smith MT, Roberts JA. Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation. J Crit Care. 2012;27:741.e9-741.e18.","journal-title":"J Crit Care"},{"key":"1585_CR5","doi-asserted-by":"publisher","DOI":"10.2147\/CPAA.S26582","author":"CG Hughes","year":"2012","unstructured":"Hughes CG, McGrane S, Pandharipande PP. Sedation in the intensive care setting. Clin Pharmacol Adv Appl. 2012. https:\/\/doi.org\/10.2147\/CPAA.S26582.","journal-title":"Clin Pharmacol Adv Appl"},{"key":"1585_CR6","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1001\/jama.283.11.1451","volume":"283","author":"ME Ostermann","year":"2000","unstructured":"Ostermann ME, Keenan SP, Seiferling RA, Sibbald WJ. Sedation in the intensive care unit: a systematic review. JAMA. 2000;283:1451\u2013549.","journal-title":"JAMA"},{"key":"1585_CR7","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1097\/CCM.0000000000005626","volume":"50","author":"BM Fuller","year":"2022","unstructured":"Fuller BM, Pappal RD, Mohr NM, Roberts BW, Faine B, Yeary J, et al. Awareness with paralysis among critically ill emergency department patients: a prospective cohort study. Crit Care Med. 2022;50:1449\u201360.","journal-title":"Crit Care Med"},{"key":"1585_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/bja\/aes386","volume":"110","author":"CD Kent","year":"2013","unstructured":"Kent CD, Mashour GA, Metzger NA, Posner KL, Domino KB. Psychological impact of unexpected explicit recall of events occurring during surgery performed under sedation, regional anaesthesia, and general anaesthesia: data from the Anesthesia Awareness Registry. Br J Anaesth. 2013;110:381\u20137.","journal-title":"Br J Anaesth"},{"key":"1585_CR9","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1213\/ANE.0b013e3181b8b6ca","volume":"110","author":"K Leslie","year":"2010","unstructured":"Leslie K, Chan MTV, Myles PS, Forbes A, McCulloch TJ. Posttraumatic stress disorder in aware patients from the B-aware trial. Anesth Analg. 2010;110:823\u20138.","journal-title":"Anesth Analg"},{"key":"1585_CR10","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.annemergmed.2020.10.012","volume":"77","author":"RD Pappal","year":"2021","unstructured":"Pappal RD, Roberts BW, Mohr NM, Ablordeppey E, Wessman BT, Drewry AM, et al. The ED-AWARENESS study: a prospective, observational cohort study of awareness with paralysis in mechanically ventilated patients admitted from the emergency department. Ann Emerg Med. 2021;77:532\u201344.","journal-title":"Ann Emerg Med"},{"key":"1585_CR11","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1056\/NEJM200005183422002","volume":"342","author":"JP Kress","year":"2000","unstructured":"Kress JP. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000;342:1471\u20137.","journal-title":"N Engl J Med"},{"key":"1585_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S0140-6736(08)60105-1","volume":"371","author":"TD Girard","year":"2008","unstructured":"Girard TD, Kress JP, Fuchs BD, Thomason JWW, Schweickert WD, Pun BT, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (awakening and breathing controlled trial): a randomised controlled trial. Lancet. 2008;371:126\u201334.","journal-title":"Lancet"},{"key":"1585_CR13","unstructured":"Propofol [Internet]. Drugbank. [cited 2025 Apr 11]. https:\/\/go.drugbank.com\/drugs\/DB00818. Accessed 8 Sept 2025."},{"key":"1585_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13054-015-0891-z","volume":"19","author":"K Shekar","year":"2015","unstructured":"Shekar K, Roberts JA, Mcdonald CI, Ghassabian S, Anstey C, Wallis SC, et al. Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo study. Crit Care. 2015;19:164.","journal-title":"Crit Care"},{"key":"1585_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/026765910001500104","volume":"15","author":"H Mulla","year":"2000","unstructured":"Mulla H, Lawson G, von Anrep C, Burke MD, Upton DU, Firmin RK, et al. In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation. Perfusion. 2000;15:21\u20136.","journal-title":"Perfusion"},{"key":"1585_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13054-015-0772-5","volume":"19","author":"F Lemaitre","year":"2015","unstructured":"Lemaitre F, Hasni N, Leprince P, Corvol E, Belhabib G, Fill\u00e2tre P, et al. Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood. Crit Care. 2015;19:40.","journal-title":"Crit Care"},{"key":"1585_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1208\/s12248-023-00817-2","volume":"25","author":"N Khurana","year":"2023","unstructured":"Khurana N, S\u00fcnner T, Hubbard O, Imburgia C, Stoddard GJ, Yellepeddi V, et al. Micellar encapsulation of propofol reduces its adsorption on extracorporeal membrane oxygenator (ECMO) circuit. AAPS J. 2023;25:52.","journal-title":"AAPS J"},{"key":"1585_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13054-016-1242-4","volume":"20","author":"C Roth","year":"2016","unstructured":"Roth C, Schrutka L, Binder C, Kriechbaumer L, Heinz G, Lang IM, et al. Liver function predicts survival in patients undergoing extracorporeal membrane oxygenation following cardiovascular surgery. Crit Care. 2016;20:57.","journal-title":"Crit Care"},{"key":"1585_CR19","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s40262-018-0672-3","volume":"57","author":"MM Sahinovic","year":"2018","unstructured":"Sahinovic MM, Struys MMRF, Absalom AR. Clinical pharmacokinetics and pharmacodynamics of propofol. Clin Pharmacokinet. 2018;57:1539\u201358.","journal-title":"Clin Pharmacokinet"},{"key":"1585_CR20","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.clinthera.2018.07.021","volume":"40","author":"AHW Tse","year":"2018","unstructured":"Tse AHW, Ling L, Lee A, Joynt GM. Altered pharmacokinetics in prolonged infusions of sedatives and analgesics among adult critically ill patients: a systematic review. Clin Ther. 2018;40:1598-1615.e2.","journal-title":"Clin Ther"},{"key":"1585_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1513\/AnnalsATS.202407-795OC","volume":"22","author":"D Morales Castro","year":"2025","unstructured":"Morales Castro D, Balzani E, Abdul-Aziz MH, Hernandez-Mitre MP, Wong I, Turgeon J, et al. Propofol and fentanyl pharmacokinetics and pharmacodynamics in extracorporeal membrane oxygenation. Ann Am Thorac Soc. 2025;22:121\u20139.","journal-title":"Ann Am Thorac Soc"},{"key":"1585_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2021.462360","volume":"1652","author":"KM Lee","year":"2021","unstructured":"Lee KM, Han SM, Lee S, Jeong TY, Kim HJ, Min H, et al. Fluoride-assisted liquid chromatography-tandem mass spectrometry method for simultaneous analysis of propofol and its metabolites without derivatization in urine. J Chromatogr A. 2021;1652:462360.","journal-title":"J Chromatogr A"},{"key":"1585_CR23","unstructured":"European Medicines Agency. ICH guideline M10 on bioanalytical method validation and study sample analysis [Internet]. 2022 [cited 2023 Apr 27]. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-guideline-m10-bioanalytical-method-validation-step-5_en.pdf. Accessed 8 Sept 2025."},{"key":"1585_CR24","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1021\/ac020361s","volume":"75","author":"BK Matuszewski","year":"2003","unstructured":"Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC\u2212MS\/MS. Anal Chem. 2003;75:3019\u201330.","journal-title":"Anal Chem"},{"key":"1585_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/biomet\/52.3-4.591","volume":"52","author":"SS Shapiro","year":"1965","unstructured":"Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika. 1965;52:591\u2013611.","journal-title":"Biometrika"},{"key":"1585_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2307\/3001968","volume":"1","author":"F Wilcoxon","year":"1945","unstructured":"Wilcoxon F. Individual comparisons by ranking methods. Biometr Bull. 1945;1:80\u20133.","journal-title":"Biometr Bull"},{"key":"1585_CR27","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1208\/s12248-009-9133-0","volume":"11","author":"RM Savic","year":"2009","unstructured":"Savic RM, Karlsson MO. Importance of shrinkage in empirical Bayes estimates for diagnostics: problems and solutions. AAPS J. 2009;11:558\u201369.","journal-title":"AAPS J"},{"key":"1585_CR28","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1208\/s12248-012-9407-9","volume":"14","author":"XS Xu","year":"2012","unstructured":"Xu XS, Yuan M, Karlsson MO, Dunne A, Nandy P, Vermeulen A. Shrinkage in nonlinear mixed-effects population models: quantification, influencing factors, and impact. AAPS J. 2012;14:927\u201336.","journal-title":"AAPS J"},{"key":"1585_CR29","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/00000542-200108000-00011","volume":"95","author":"J Barr","year":"2001","unstructured":"Barr J, Cohane C. Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic\u2013pharmacodynamic model. Anesthesiology. 2001;95:324\u201333.","journal-title":"Anesthesiology"},{"key":"1585_CR30","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/sj.clpt.6100309","volume":"83","author":"M Peeters","year":"2008","unstructured":"Peeters M, Bras L, DeJongh J, Wesselink R, Aarts L, Danhof M, et al. Disease severity is a major determinant for the pharmacodynamics of propofol in critically ill patients. Clin Pharmacol Ther. 2008;83:443\u201351.","journal-title":"Clin Pharmacol Ther"},{"key":"1585_CR31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10928-010-9161-5","volume":"37","author":"A Bienert","year":"2010","unstructured":"Bienert A, Kusza K, Wawrzyniak K, Grze\u015bkowiak E, Kokot ZJ, Matysiak J, et al. Assessing circadian rhythms in propofol PK and PD during prolonged infusion in ICU patients. J Pharmacokinet Pharmacodyn. 2010;37:289\u2013304.","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"1585_CR32","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/bdd.2028","volume":"37","author":"P Smuszkiewicz","year":"2016","unstructured":"Smuszkiewicz P, Wiczling P, Przyby\u0142owski K, Borsuk A, Trojanowska I, Paterska M, et al. The pharmacokinetics of propofol in ICU patients undergoing long-term sedation. Biopharm Drug Dispos. 2016;37:456\u201366.","journal-title":"Biopharm Drug Dispos"},{"key":"1585_CR33","first-page":"101","volume":"73","author":"A Iida","year":"2019","unstructured":"Iida A, Naito H, Yorifuji T, Zamami Y, Yamada A, Koga T, et al. Factors affecting the absorption of midazolam to the extracorporeal membrane oxygenation circuit. Acta Med Okayama. 2019;73:101\u20137.","journal-title":"Acta Med Okayama"},{"key":"1585_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/MAT.0000000000000793","volume":"65","author":"VG Nasr","year":"2019","unstructured":"Nasr VG, Meserve J, Pereira LM, Faraoni D, Brediger S, Goobie S, et al. Sedative and analgesic drug sequestration after a single bolus injection in an ex vivo extracorporeal membrane oxygenation infant circuit. ASAIO J. 2019;65:187\u201391.","journal-title":"ASAIO J"},{"key":"1585_CR35","first-page":"288","volume":"19","author":"AA Harthan","year":"2014","unstructured":"Harthan AA, Buckley KW, Heger ML, Fortuna RS, Mays K. Medication adsorption into contemporary extracorporeal membrane oxygenator circuits. J Pediatr Pharmacol Ther. 2014;19:288\u201395.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"1585_CR36","doi-asserted-by":"publisher","first-page":"R194","DOI":"10.1186\/cc11679","volume":"16","author":"K Shekar","year":"2012","unstructured":"Shekar K, Roberts JA, Mcdonald CI, Fisquet S, Barnett AG, Mullany DV, et al. Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation. Crit Care. 2012;16:R194.","journal-title":"Crit Care"},{"key":"1585_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/0267659119868062","volume":"35","author":"SH Dallefeld","year":"2020","unstructured":"Dallefeld SH, Sherwin J, Zimmerman KO, Watt KM. Dexmedetomidine extraction by the extracorporeal membrane oxygenation circuit: results from an in vitro study. Perfusion. 2020;35:209\u201316.","journal-title":"Perfusion"},{"key":"1585_CR38","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1051\/ject\/2024016","volume":"56","author":"A Chevalier","year":"2024","unstructured":"Chevalier A, Porter Hunt J, Whelan A, McKnite A, Watt KM, Green DJ. Extraction of ketamine and dexmedetomidine by extracorporeal life support circuits. J Extracorporeal Technol. 2024;56:101\u20137.","journal-title":"J Extracorporeal Technol"},{"key":"1585_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/00002480-200301000-00007","volume":"49","author":"H Mulla","year":"2003","unstructured":"Mulla H, Lawson G, Peek GJ, Firmin RK, Upton DR. Plasma concentrations of midazolam in neonates receiving extracorporeal membrane oxygenation. ASAIO J. 2003;49:41\u20137.","journal-title":"ASAIO J"},{"key":"1585_CR40","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2165\/11319970-000000000-00000","volume":"49","author":"MJ Ahsman","year":"2010","unstructured":"Ahsman MJ, Hanekamp M, Wildschut ED, Tibboel D, Mathot RAA. Population pharmacokinetics of Midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates. Clin Pharmacokinet. 2010;49:407\u201319.","journal-title":"Clin Pharmacokinet"},{"key":"1585_CR41","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/00000542-200308000-00008","volume":"99","author":"H Mulla","year":"2003","unstructured":"Mulla H, McCormack P, Lawson G, Firmin RK, Upton DR. Pharmacokinetics of midazolam in neonates undergoing extracorporeal membrane oxygenation. Anesthesiology. 2003;99:275\u201382.","journal-title":"Anesthesiology"},{"key":"1585_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.924829","volume":"10","author":"C Thibault","year":"2022","unstructured":"Thibault C, Zuppa AF. Dexmedetomidine in children on extracorporeal membrane oxygenation: pharmacokinetic data exploration using previously published models. Front Pediatr. 2022;10:924829.","journal-title":"Front Pediatr"},{"key":"1585_CR43","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/02676591221134941","volume":"39","author":"S Farrokh","year":"2024","unstructured":"Farrokh S, Kim BS, Cho S-M. Ketamine infusion for sedation in a patient on extracorporeal membrane oxygenation (ECMO). Perfusion. 2024;39:223\u20136.","journal-title":"Perfusion"},{"key":"1585_CR44","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.clinthera.2019.03.005","volume":"41","author":"E Lam","year":"2019","unstructured":"Lam E, Rochani A, Kaushal G, Thoma BN, Tanjuakio J, West FM, et al. Pharmacokinetics of ketamine at dissociative doses in an adult patient with refractory status asthmaticus receiving extracorporeal membrane oxygenation therapy. Clin Ther. 2019;41:994\u20139.","journal-title":"Clin Ther"},{"key":"1585_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcrc.2016.07.020","volume":"37","author":"JR DeGrado","year":"2017","unstructured":"DeGrado JR, Hohlfelder B, Ritchie BM, Anger KE, Reardon DP, Weinhouse GL. Evaluation of sedatives, analgesics, and neuromuscular blocking agents in adults receiving extracorporeal membrane oxygenation. J Crit Care. 2017;37:1\u20136.","journal-title":"J Crit Care"},{"issue":"6","key":"1585_CR46","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/phar.1760","volume":"36","author":"CD Nigoghossian","year":"2016","unstructured":"Nigoghossian CD, Dzierba AL, Etheridge J, Roberts R, Muir J, Brodie D, et al. Effect of extracorporeal membrane oxygenation use on sedative requirements in patients with severe acute respiratory distress syndrome. Pharmacotherapy. 2016;36(6):607\u201316.","journal-title":"Pharmacotherapy"},{"key":"1585_CR47","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1177\/0310057X1204000411","volume":"40","author":"K Shekar","year":"2012","unstructured":"Shekar K, Roberts JA, Mullany DV, Corley A, Fisquet S, Bull TN, et al. Increased sedation requirements in patients receiving extracorporeal membrane oxygenation for respiratory and cardiorespiratory failure. Anaesth Intensive Care. 2012;40:648\u201355.","journal-title":"Anaesth Intensive Care"}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-025-01585-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40262-025-01585-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-025-01585-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T12:03:05Z","timestamp":1770379385000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40262-025-01585-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1585"],"URL":"https:\/\/doi.org\/10.1007\/s40262-025-01585-2","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Thierry Buclin is an Editorial Board member of Clinical Pharmacokinetics. He was not involved in the selection of peer reviewers for the manuscript or any of the subsequent editorial decisions. The other authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Elements supporting the main results of the present work are presented within the article and its online supplementary information. Further data used in the frame of this study are available on reasonable request from the corresponding author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"The Ethics Committees of the Cantons of Vaud (Commission cantonale d'\u00e9thique de la recherche sur l'\u00eatre humain, CER-VD) and Geneva (Commission cantonale d'\u00e9thique de la recherche sur l'\u00eatre humain, CCER) approved the study in December 2022 (project-ID 2022-01262).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all participants in the study or their therapeutic representatives.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The NONMEM code for the final model is reproduced in Supplementary information Table 1.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"SB, LAD, AS, TB, MG and FL designed the study. SB, DH, CB, RG, BA, AS and FL were involved in patient recruitment and data collection. TM and LAD were responsible for the propofol analytical method development, validation and plasma quantification. SB, MG, TB and FL analysed the data. TB, MG and FL provided general supervision of the project. SB and FL wrote the manuscript, and all authors revised and approved the final version.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}